News

ascopubs.org1d
A phase II study of chemoselection with docetaxel, cisplatin, and 5–fluorouracil as a strategy for organ preservation in patients with resectable esophageal cancer (CROC trial).
Neoadjuvant nivolumab monotherapy in patients with resectable gastric cancer: Preliminary results from a multicenter study. This is an ASCO Meeting Abstract from the 2021 ASCO Annual Meeting I. This ...